Format

Send to

Choose Destination
See comment in PubMed Commons below
Addict Behav. 2006 Jul;31(7):1144-52. Epub 2005 Aug 30.

The prevalence of weight concerns in a smoking abstinence clinical trial.

Author information

1
Mayo Clinic - Mayo Building-W11, 200 First Street, SW, Rochester, MN 55905, USA. Clark.matthew@mayo.edu

Abstract

Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p=0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.

PMID:
16137833
DOI:
10.1016/j.addbeh.2005.08.011
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center